Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cervical hyoscine for shortening the first and second stages of labor
IRCT20181219042051N3Phase 3Completed
- Sponsor
- Rafsanjan University of Medical Sciences
- Start
- Apr 2021
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of scopolamine in childbirth (2 arms), sponsored by Rafsanjan University of Medical Sciences. Primary endpoints: Length of the first stage of labor and Length of the second stage of labor. Started Apr 2021; status: completed.
02
Drugs
scopolamine
03
Conditions
childbirth
Beyond the preview
Go deeper on IRCT20181219042051N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181219042051N3.